| Line Item | 2025-02-28 | Y/Y |
|---|---|---|
| Revenue | $534.9M | -37.3% |
| Cost of Revenue | $140.0M | -58.0% |
| Gross Profit | $394.9M | -24.1% |
| R&D Expense | $108.8M | -41.5% |
| SG&A Expense | $159.7M | -11.8% |
| Operating Income | $800K | +100.6% |
| Interest Expense | $6.0M | +0.0% |
| Pre-tax Income | $8.5M | +108.0% |
| Income Tax | $17.0M |
| Line Item | 2025-02-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $266.7M | +52.4% |
| Short-term Investments | $71.1M | +14.7% |
| Accounts Receivable | $173.7M | -12.7% |
| Current Assets | $591.5M | +16.4% |
| Total Assets | $1.30B | -7.1% |
| Current Liabilities | $344.3M | -3.3% |
| Long-term Debt | $195.3M | +0.7% |
| Line Item | 2025-02-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $16.5M | +650.0% |
| Capital Expenditures | $3.1M | -55.7% |
| Investing Cash Flow | $60.7M | +32.0% |
| Financing Cash Flow | $3.1M | +101.9% |
| Free Cash Flow | $13.4M | +234.0% |
| -29.2% |
| Net Income | -$79.0M | +39.2% |
| EPS (Basic) | -$0.13 | +40.9% |
| EPS (Diluted) | -$0.13 | +40.9% |
| Total Liabilities |
| $575.7M |
| -7.0% |
| Stockholders' Equity | $719.9M | -7.2% |